Day: March 4, 2025

Volition’s Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Nu.Q® Discover tools provide drug developers and scientists with a range of rapid epigenetic profiling assays across pre-clinical and clinical development...

WELL Health Provides Corporate Update Highlighting Canadian Clinics Growth Momentum and Record Pipeline of Canadian Public Sector Business Opportunities Amidst Surge of ‘Buy Canadian’ Sentiment

error: Content is protected !!